International PRISMA scoping review to understand mental health interventions for depression in COVID-19 patients
Open accessAbstract
Preliminary research indicates that the COVID-19 illness affects the mental well-being of patients. This scoping review, thus, aims to examine the current state of research into mental health treatments for depression symptoms in COVID-19 patients. Select databases were searched on 7/1/2021. Full-text articles involved (1) mental health treatment (2) suicide and/or depression outcomes, (3) a quasi-experimental research trial, and (4) a primary analysis. 11 articles were included in this review. The studies spanned 5 countries, and demonstrated immediate positive effects of mental health treatments and tele-health as a treatment modality for depression in COVID-19 patients. 6 studies were randomized controlled trials. Various treatments were administered, including cognitive behavior therapy, mindfulness, and muscle relaxation. Most interventions were conducted in in-patient units and focused on acute symptoms. There were limitations in the design and description of methodology in many studies, which affects the generalizability and replicability of positive findings. Only two studies included a post-intervention follow-up and one study assessed suicide risk. Thus, this review found there is a pressing need for more research in the area, with greater rigor in study methodology, and for treatments targeting long-term symptoms and suicidality, and outpatient services.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Specific symptom-based interventions are usually provided, which makes it difficult to address comorbid EDs such as anxiety and depressive symptoms simultaneously present in COVID-19 patients.
“Second, specific symptom-based interventions are usually provided (Chennapragada et al., 2022), which makes it difficult to address comorbid EDs, for instance, anxiety and depressive symptoms that are simultaneously present in COVID-19 patients (Joli et al., 2022).”
From Unified Protocol for the transdiagnostic treatment of emotional disorders in people with post COVID-19 condition: study protocol for a multiple baseline n-of-1 trial (2023) · cites this paper as Chennapragada et al., 2022
Another scoping review investigated psychological interventions targeting depressive or suicidal symptoms for people diagnosed with COVID-19 and identified 11 studies conducted between February and June 2020.
“Another scoping review investigated the psychological interventions targeting depressive or suicidal symptoms for people diagnosed with COVID-19.20 The authors identified a total of 11 studies conducted in the early stages of the pandemic, specifically between February and June 2020.”
From Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol (2023) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 56 · Cited by 13
Research works printed but not linked: 1
- COVIDence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at www.COVIDence.org.
- Authors
- Chennapragada, L., Sullivan, S. R., Hamerling-Potts, K. K., Tran, H., Szeszko, J., Wrobleski, J., Mitchell, E. L., Walsh, S., & Goodman, M.
- Affiliations
- James J. Peters VA Medical Center (US)
- Mount Sinai Hospital (US)
- Corresponding author
- Chennapragada, Lakshmi
- ORCID
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 2022-10
- Volume
- 316
- Pages
- 114748
- ISSN
- 0165-1781 (ISSN-L)
- PMC
- PMC9313534
- OpenAlex
- W4287733385
- Cited by
- 13
- References
- 56
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 9 · 2022: 1
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Psychiatry Research (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- VISN 4 Mental Illness Research, Education, and Clinical Center
- Topics
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- depression, COVID-19 pandemic, mental health interventions, telemedicine, cognitive behavioral therapy, mindfulness, muscle relaxation, suicide risk, inpatient care
- MeSH terms
- COVID-19, Depression, Humans, Mental Health, Cognitive Behavioral Therapy, Mindfulness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
